Residual products of the chemical or allied industries, not elsewhere specified or included: clinical waste

In 2024, residual products of the chemical or allied industries, not elsewhere specified or included: clinical waste trade exhibited slight decline, with global flows reaching $35,719,842 and a three-year compound annual growth rate of +67.5% (five-year: +69.7%). The all-time peak of $92,962,395 was recorded in 2000; the current level is 62% below that high-water mark.

Over the 30-year observation window (1995–2024), 52% of years recorded positive growth, indicating a mildly upward trajectory with periodic contractions. Trend momentum is strengthening (+27.5% acceleration).

The supply side is concentrated (Herfindahl-Hirschman Index 0.734). The three largest exporters — United States ($31.3M), Slovakia ($3.0M), and Japan ($1.6M) — collectively dominate supply flows. The leading exporter has grown at +282.6% over the last three years.

On the demand side, importer concentration is concentrated (HHI 0.725). The three largest import markets are Mexico ($30.3M), United States ($2.3M), and Sweden ($1.1M). The largest importing market sources from 18 different supplying countries.

Estimated substitution elasticity: -5.46. Buyers are highly price-sensitive and can switch between suppliers relatively easily.

The dominant trade corridor is United States → Mexico at $30.2M, representing 99.5% of the importer's total demand.

The volatility score for residual products of the chemical or allied industries, not elsewhere specified or included: clinical waste is 23 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.